These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 21377285)

  • 1. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
    Aristophanous M; Berbeco RI; Killoran JH; Yap JT; Sher DJ; Allen AM; Larson E; Chen AB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e99-105. PubMed ID: 21377285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.
    Aristophanous M; Yong Y; Yap JT; Killoran JH; Allen AM; Berbeco RI; Chen AB
    Radiother Oncol; 2012 Mar; 102(3):377-82. PubMed ID: 22265731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation?
    Rodríguez N; Sanz X; Trampal C; Foro P; Reig A; Lacruz M; Membrive I; Lozano J; Quera J; Algara M
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):659-66. PubMed ID: 20133071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
    Geiger GA; Kim MB; Xanthopoulos EP; Pryma DA; Grover S; Plastaras JP; Langer CJ; Simone CB; Rengan R
    Clin Lung Cancer; 2014 Jan; 15(1):79-85. PubMed ID: 24238934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
    Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
    van Loon J; Siedschlag C; Stroom J; Blauwgeers H; van Suylen RJ; Knegjens J; Rossi M; van Baardwijk A; Boersma L; Klomp H; Vogel W; Burgers S; Gilhuijs K
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):448-56. PubMed ID: 20971575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
    Siepel FJ; de Bruin WI; van Duyn EB; Steenvoorde P; Wagenaar NR; Slump CH; van Dalen JA
    Nucl Med Commun; 2012 Apr; 33(4):439-44. PubMed ID: 22311052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET motion compensation for radiation therapy using a CT-based mid-position motion model: methodology and clinical evaluation.
    Kruis MF; van de Kamer JB; Houweling AC; Sonke JJ; Belderbos JS; van Herk M
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):394-400. PubMed ID: 23910710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
    Hanna GG; McAleese J; Carson KJ; Stewart DP; Cosgrove VP; Eakin RL; Zatari A; Lynch T; Jarritt PH; Young VA; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):24-30. PubMed ID: 19665324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geometrical differences in target volumes based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and four-dimensional computed tomography maximum intensity projection images of primary thoracic esophageal cancer.
    Guo Y; Li J; Wang W; Zhang Y; Wang J; Duan Y; Shang D; Fu Z
    Dis Esophagus; 2014; 27(8):744-50. PubMed ID: 24915760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.
    Nestle U; Schaefer-Schuler A; Kremp S; Groeschel A; Hellwig D; Rübe C; Kirsch CM
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):453-62. PubMed ID: 17058078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
    Devic S; Tomic N; Faria S; Menard S; Lisbona R; Lehnert S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1555-62. PubMed ID: 20646840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity.
    Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):350-6. PubMed ID: 20457349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer.
    Lin P; Koh ES; Lin M; Vinod SK; Ho-Shon I; Yap J; Som S
    Radiother Oncol; 2011 Nov; 101(2):284-90. PubMed ID: 21777988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.